摘要
目的研究伊曲康唑自乳化给药系统(ITZ-SEDDS)的处方工艺。方法通过溶解度实验?处方配伍和伪三相图的绘制,以自乳化时间?色泽和粒径的大小为指标,筛选油相、表面活性剂、助表面活性剂的最佳搭配和处方配比。并对ITZ-SEDDS的理化性质和体外溶出度进行了测定。结果伊曲康唑自乳化最终优化处方为:Maisine 35-1-Cremophor EL-Transcutol P=25∶30∶45。ITZ-SEDDS的粒径为162.5 nm,自乳化时间<1 min,ITZ-SEDDS在人工肠液中2 h累积溶出百分率为90.9%,是原药(0.52%)的174.8倍,市售胶囊(10.1%)的9.0倍。结论所制备的ITZ-SEDDS达到了设计要求,为ITZ的新制剂开发提供了实验依据。
Abstract
OBJECTIVE To develop the formulation of self-emulsifying drug delivery system for itraconazole(ITZ-SEDDS).METHODS The optimum formulations of ITZ-SEDDS were screened by solubility experiments,compatibility tests and pseudo-ternary phase diagrams,with the time of formulating emulsion,the consequence of visual examination and particle size as parameters.And the physic-chemical characters and dissolution in vitro of ITZ-SEDDS were also determined.RESULTS The optimum self-emulsifying drug delivery system was composed of Maisine 35-1(25%),Cremophor EL(30%) and Transcutol P(45%).The particle diameter was 162.5 nm,the time of self-microemulsifying was less than 1 min.The percent of accumulated dissolution of itraconazole in SEDDS in simulated intenstinal fluid was up to 90.9% at 2 h,which was 174.8 times as much as that of ITZ crude powder,and 9.0 times as much as that of ITZ capsules.CONCLUSION The formulation of ITZ-SEDDS prepared achieved the requirement of design.It could provide reference for the new dosage form of itraconazole.
关键词
伊曲康唑 /
自乳化释药系统 /
处方研究 /
体外溶出度
{{custom_keyword}} /
Key words
itraconazole /
self-emulsifying drug delivery system /
formulation design /
dissolution in vitro
{{custom_keyword}} /
陈鹰;郑庆玲;刘宏;辛华雯.
伊曲康唑自乳化释药系统的处方研究[J]. 中国药学杂志, 2008, 43(22): 1714-1718
CHEN Ying;ZHENG Qing-ling;LIU Hong;XIN Hu-wen.
Study on Itraconazole Self-Emulsifying Drug Delivery System [J]. Chinese Pharmaceutical Journal, 2008, 43(22): 1714-1718
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] BARONE J A，KOH J G，BIERMAN R H，et al. Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers[J] .Antimicrob Agents Chemother，1993，37（4）：778-784.
[2] HASSAN H A，AL-MARZOUQI A H，JOBE B，et al. Enhan- cement of dissolution amount and in vivo bioavailability of itraconazole by complexation with beta-cyclodextrin using supercritical carbon dioxide[J] . J Pharm Biomed Anal，2007，45(2)：243-250.
[3] BARONE J A，MOSKOVITZ B L，GUARNIERI J，et al. Enhan- ced bioavailability of itraconazole in hydroxypropyl- beta- cyclodextrin solution versus capsules in healthy volunteers[J] . Antimicrob Agents Chemother，1998 ，42(7)：1862-1865.
[4] GURSOY R N，BENITA S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs[J] . Biomed Pharmacother，2004，58（3）：173-182.
[5] KONG B B，WANG S L，SU D S，et al. Studies on preparation and properties of itraconazole emulsion for intravenous administration[J] . Chin J Pharm (中国药剂学杂志)，2006，4(1)：7-11.
[6] ZIMMERMANN T，YEATES R A，LAUFEN H，et al. Influence of concomitant food intake on the oral absorption of two triazole antifungal agents，itraconazole and fluconazole[J] . Eur J Clin Pharmacol，1994，46（2）：147-150.
[7] CHEN Y, LI G, WU X G, et al. Self-microemulsifying drug delivery system(SMEDDS) of vinpocetine: formulation development and in vivo assessment[J] . Bio Pharm Bull，2008，31（1）：118-125.
[8] SONG Y，CHANG D，WANG D K，et al. Formulation selection and study of dissolution in vitro on liquid hard capsules of daidzein[J] . J Shenyang Pharm Univ(沈阳药科大学学报)，2008，2(2)：96-100.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
